Pegylated Interferon Alfa-2a for Dialysis Patients With Acute Hepatitis C
Status:
Completed
Trial end date:
2008-06-01
Target enrollment:
Participant gender:
Summary
Interferon-based monotherapy has been considered effective to treat acute hepatitis C in
ordinary patients. However, the efficacy of this treatment has not been evaluated in
prospective interventional studies for dialysis patients. The aim of the study is the
evaluate the efficacy of peginterferon alfa-2a monotherapy for 24 weeks in this special
clinical setting, and concomitantly evaluate retrospectively the dialysis patients with acute
hepatitis C who did not receive intervention as the reference.